RBOT logo

Vicarious Surgical (RBOT) Stock

Profile

Sector:

Healthcare

Country:

United States

IPO:

04 September 2020

Indexes:

Not included

Description:

RBOT, developed by Vicarious Surgical, is a robotic surgical system designed to enhance minimally invasive surgeries. It combines advanced robotics and virtual reality to assist surgeons, improving precision and patient outcomes while reducing recovery times. The technology aims to transform traditional surgical practices for better healthcare solutions.

Events Calendar

Earnings

Next earnings date:

Mar 04, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 04, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

June 13, 2024

Analyst ratings

Recent major analysts updates

13 Aug '24 Piper Sandler
Neutral
05 Mar '24 Piper Sandler
Neutral
04 Dec '23 Morgan Stanley
Equal-Weight
14 Nov '23 Canaccord Genuity
Hold
14 Nov '23 BTIG
Neutral
31 May '23 Canaccord Genuity
Buy
18 July '22 BTIG
Buy
10 May '22 Piper Sandler
Neutral
04 Mar '22 Piper Sandler
Neutral
04 Mar '22 Canaccord Genuity
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Vicarious Surgical Inc (RBOT) Q2 2024 Earnings Call Transcript
Vicarious Surgical Inc (RBOT) Q2 2024 Earnings Call Transcript
Vicarious Surgical Inc (RBOT) Q2 2024 Earnings Call Transcript
RBOT
seekingalpha.com12 August 2024

Vicarious Surgical Inc (NYSE:RBOT ) Q2 2024 Results Conference Call August 12, 2024 4:30 PM ET Company Participants Kaitlyn Brosco - IR Bill Kelly - CFO & Treasurer Adam Sachs - Co-Founder, CEO & Director Conference Call Participants Eric Anderson - TD Cowen Andrew Ranieri - Morgan Stanley Ryan Zimmerman - BTIG Operator Good afternoon. Thank you for attending the Vicarious Surgical's 2024 Second Quarter Earnings Call.

Vicarious Surgical (RBOT) Partners LSU Health New Orleans
Vicarious Surgical (RBOT) Partners LSU Health New Orleans
Vicarious Surgical (RBOT) Partners LSU Health New Orleans
RBOT
zacks.com08 August 2024

Vicarious Surgical (RBOT) teams up with LSU Health New Orleans to advance its V1.0 surgical robot. It aims to file for FDA approval by 2026.

Vicarious Surgical Announces Reverse Stock Split
Vicarious Surgical Announces Reverse Stock Split
Vicarious Surgical Announces Reverse Stock Split
RBOT
businesswire.com10 June 2024

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives through the transformation of surgical robotics, today announced it will effect a 1-for-30 reverse stock split of the Company's issued and outstanding Class A common stock, par value $0.0001 per share, and Class B common stock, par value $0.0001 per share. The reverse stock split was approved by Vicarious S.

RBOT Stock Earnings: Vicarious Surgical Meets EPS for Q1 2024
RBOT Stock Earnings: Vicarious Surgical Meets EPS for Q1 2024
RBOT Stock Earnings: Vicarious Surgical Meets EPS for Q1 2024
RBOT
InvestorPlace29 April 2024

Vicarious Surgical (NYSE: RBOT) recently released their first quarter results for 2024, with earnings per share of -9 cents.

Vicarious Surgical Inc. (RBOT) Q1 2024 Earnings Call Transcript
Vicarious Surgical Inc. (RBOT) Q1 2024 Earnings Call Transcript
Vicarious Surgical Inc. (RBOT) Q1 2024 Earnings Call Transcript
RBOT
Seeking Alpha29 April 2024

Vicarious Surgical Inc. (NYSE:RBOT) will be hosting its Q1 2024 Earnings Conference Call on April 29, 2024 at 4:30 PM ET. The call will feature Kaitlyn Brosco, Adam Sachs, Bill Kelly, and Randy Clark. Participants include Ryan Zimmerman, Adam Maeder, and Josh Jennings. The operator will start the call by welcoming everyone to Vicarious Surgical's 2024 First Quarter Earnings Call.

Vicarious Surgical Inc. (RBOT) Q4 2023 Earnings Call Transcript
Vicarious Surgical Inc. (RBOT) Q4 2023 Earnings Call Transcript
Vicarious Surgical Inc. (RBOT) Q4 2023 Earnings Call Transcript
RBOT
Seeking Alpha04 March 2024

Vicarious Surgical Inc. (NYSE:RBOT ) Q4 2023 Earnings Conference Call March 4, 2024 4:30 PM ET Company Participants Kaitlyn Brosco - IR Adam Sachs - CEO William Kelly - CFO Conference Call Participants Ryan Zimmerman - BTIG Operator Good afternoon, and welcome to Vicarious Surgical's Fourth Quarter 2023 Earnings Conference Call. My name is Matt, and I'll be your operator for today's call.

Vicarious Surgical Inc. (RBOT) Q3 2023 Earnings Call Transcript
Vicarious Surgical Inc. (RBOT) Q3 2023 Earnings Call Transcript
Vicarious Surgical Inc. (RBOT) Q3 2023 Earnings Call Transcript
RBOT
Seeking Alpha13 November 2023

Vicarious Surgical Inc. (NYSE:RBOT ) Q3 2023 Earnings Conference Call November 13, 2023 4:30 PM ET Company Participants Kaitlyn Brosco - Investor Relations Adam Sachs - Chief Executive Officer Bill Kelly - Chief Financial Officer Conference Call Participants Ryan Zimmerman - BTIG Adam Maeder - Piper Sandler Josh Jennings - TD Cohen Caitlin Cronin - Canaccord Genuity Operator Good afternoon, and welcome to Vicarious Surgical's Third Quarter 2023 Earnings Conference Call. My name is Kate, and I'll be your operator for today's call.

Vicarious Surgical (RBOT) to Broaden User Network With New Deal
Vicarious Surgical (RBOT) to Broaden User Network With New Deal
Vicarious Surgical (RBOT) to Broaden User Network With New Deal
RBOT
Zacks Investment Research14 September 2023

Vicarious Surgical's (RBOT) partnership with Intermountain Health is likely to help the company gain access to Intermountain Health's extensive network.

Vicarious Surgical: Huge Potential But Low Margin Of Safety To Commercialization
Vicarious Surgical: Huge Potential But Low Margin Of Safety To Commercialization
Vicarious Surgical: Huge Potential But Low Margin Of Safety To Commercialization
RBOT
Seeking Alpha24 August 2023

Vicarious Surgical is a surgical robotics company developing a next-generation surgical robot with human-like dexterity. The company has a large addressable market of over 45 million abdominal procedures worth $150 billion, but its survival is uncertain due to low cash reserves and high burn. I am personally staying on the sidelines as I believe the risk / reward is better if/when RBOT reaches commercialization with a superior product than currently awaiting regulatory approval.

Vicarious Surgical stock tanks on discounted public offering
Vicarious Surgical stock tanks on discounted public offering
Vicarious Surgical stock tanks on discounted public offering
RBOT
Proactive Investors03 August 2023

Vicarious Surgical shares plunged more than 40% after the robotics technology company announced a public offering of its shares at a steep discount to its share price at the time.   The company said it was offering 45 million shares at a price of $1, far below its then-share price of about $1.65.

  • 1(current)
  • 2
  • 1(current)
  • 2

FAQ

  • What is the primary business of Vicarious Surgical?
  • What is the ticker symbol for Vicarious Surgical?
  • Does Vicarious Surgical pay dividends?
  • What sector is Vicarious Surgical in?
  • What industry is Vicarious Surgical in?
  • What country is Vicarious Surgical based in?
  • When did Vicarious Surgical go public?
  • Is Vicarious Surgical in the S&P 500?
  • Is Vicarious Surgical in the NASDAQ 100?
  • Is Vicarious Surgical in the Dow Jones?
  • When was Vicarious Surgical's last earnings report?
  • When does Vicarious Surgical report earnings?
  • Should I buy Vicarious Surgical stock now?

What is the primary business of Vicarious Surgical?

RBOT, developed by Vicarious Surgical, is a robotic surgical system designed to enhance minimally invasive surgeries. It combines advanced robotics and virtual reality to assist surgeons, improving precision and patient outcomes while reducing recovery times. The technology aims to transform traditional surgical practices for better healthcare solutions.

What is the ticker symbol for Vicarious Surgical?

The ticker symbol for Vicarious Surgical is NYSE:RBOT

Does Vicarious Surgical pay dividends?

No, Vicarious Surgical does not pay dividends

What sector is Vicarious Surgical in?

Vicarious Surgical is in the Healthcare sector

What industry is Vicarious Surgical in?

Vicarious Surgical is in the Medical Devices industry

What country is Vicarious Surgical based in?

Vicarious Surgical is headquartered in United States

When did Vicarious Surgical go public?

Vicarious Surgical's initial public offering (IPO) was on 04 September 2020

Is Vicarious Surgical in the S&P 500?

No, Vicarious Surgical is not included in the S&P 500 index

Is Vicarious Surgical in the NASDAQ 100?

No, Vicarious Surgical is not included in the NASDAQ 100 index

Is Vicarious Surgical in the Dow Jones?

No, Vicarious Surgical is not included in the Dow Jones index

When was Vicarious Surgical's last earnings report?

Vicarious Surgical's most recent earnings report was on 12 November 2024

When does Vicarious Surgical report earnings?

The next expected earnings date for Vicarious Surgical is 4 March 2025

Should I buy Vicarious Surgical stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions